Question 1

What is the catalog number for Tissue Total RNA, Ovary?

Accepted Answer

The catalog number for Tissue Total RNA, Ovary is CR562099.

Question 2

What sizes are available for Tissue Total RNA, Ovary?

Accepted Answer

Tissue Total RNA, Ovary is available in the following size(s): 5 µg.

Question 3

Is Tissue Total RNA, Ovary in stock?

Accepted Answer

Tissue Total RNA, Ovary is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue Total RNA, Ovary?

Accepted Answer

The safety data sheet for Tissue Total RNA, Ovary is available here: https://cdn.origene.com/sds/cr562099.pdf.

Question 5

What is Tissue Total RNA, Ovary used for?

Accepted Answer

RNA (5 µg); Ovary; Adenocarcinoma of ovary, endometrioid

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 8

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Tissue Total RNA, Ovary

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

3-tert-Butylthio-2-cyanopyridine

Collagen VI (COL6A2) (C-term) Rabbit Polyclonal Antibody

Tissue FFPE Sections, Colon

PCDH15 Mouse Monoclonal Antibody [Clone ID: OTI7F10]

N-(4-Hydroxyphenyl)piperazine-d8, Dihydrobromide

3-keto-5Beta-Abiraterone